Blennow K - Search Results

1

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease.

Moore EE, Gifford KA, Khan OA, Liu D, Pechman KR, Acosta LMY, Bell SP, Turchan M, Landman BA, Blennow K, Zetterberg H, Hohman TJ, Jefferson AL. Moore EE, et al. Among authors: blennow k. Alzheimers Dement. 2020 Jun;16(6):883-895. doi: 10.1002/alz.12087. Epub 2020 May 6. Alzheimers Dement. 2020. PMID: 32378327 Free PMC article.

2

Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Månsson JE, Svennerholm L. Blennow K, et al. Aging (Milano). 1992 Dec;4(4):301-6. Aging (Milano). 1992. PMID: 1294245

3

Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, Månsson JE, Svennerholm L. Blennow K, et al. Arch Neurol. 1991 Oct;48(10):1032-5. doi: 10.1001/archneur.1991.00530220048018. Arch Neurol. 1991. PMID: 1929894

4

Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type.

Blennow K, Wallin A, Davidsson P, Fredman P, Gottfries CG, Svennerholm L. Blennow K, et al. Alzheimer Dis Assoc Disord. 1990 Summer;4(2):79-86. Alzheimer Dis Assoc Disord. 1990. PMID: 2357340

5

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors.

Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L. Blennow K, et al. Acta Neurol Scand. 1990 Apr;81(4):323-6. doi: 10.1111/j.1600-0404.1990.tb01563.x. Acta Neurol Scand. 1990. PMID: 2360400

6

Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.

Bråne G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A. Bråne G, et al. Among authors: blennow k. Alzheimer Dis Assoc Disord. 1989 Fall;3(3):148-56. doi: 10.1097/00002093-198903030-00004. Alzheimer Dis Assoc Disord. 1989. PMID: 2477044

7

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

Blennow K, Hesse C, Fredman P. Blennow K, et al. Neuroreport. 1994 Dec 20;5(18):2534-6. doi: 10.1097/00001756-199412000-00032. Neuroreport. 1994. PMID: 7696597

8

Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?

Blennow K, Wallin A, Ekman R. Blennow K, et al. J Neural Transm Park Dis Dement Sect. 1994;8(3):183-91. doi: 10.1007/BF02260939. J Neural Transm Park Dis Dement Sect. 1994. PMID: 7748462

9

Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.

Blennow K, Davidsson P, Wallin A, Gottfries CG, Svennerholm L. Blennow K, et al. Int Psychogeriatr. 1994 Spring;6(1):13-22; discussion 59-60. doi: 10.1017/s1041610294001584. Int Psychogeriatr. 1994. PMID: 8054491

10

Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.

Heilig M, Sjögren M, Blennow K, Ekman R, Wallin A. Heilig M, et al. Among authors: blennow k. Biol Psychiatry. 1995 Aug 15;38(4):210-6. doi: 10.1016/0006-3223(94)00239-Y. Biol Psychiatry. 1995. PMID: 8547442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,088 results

Search Page